MetabolismNews.net

Metabolism Xagena

Xagena Mappa
Medical Meeting
Farmaexplorer.it
Cardiobase

Search results for "Niacin"

Merck ( MSD ) has announced that the HPS2-THRIVE ( Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events ) study of Tredaptive ( extended-release Niacin / Laropiprant ) ...


The Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events ( HPS2-THRIVE ) showed that adding extended-release Niacin-Laropiprant ( ERN-LRPT ) to statin provided no incre ...


Previous studies have suggested that Niacin treatment raises glucose levels in patients with diabetes mellitus and may increase the risk of developing diabetes. Researchers performed a meta-analysis ...